TransMedics Group Inc. (NASDAQ:TMDX) went up by 9.20% from its latest closing price compared to the recent 1-year high of $36.47. The company’s stock price has collected 26.19% of gains in the last five trading sessions. Press Release reported on 02/16/21 that TransMedics to Present at the Cowen 41st Annual Healthcare Conference
Is It Worth Investing in TransMedics Group Inc. (NASDAQ :TMDX) Right Now?
Opinions of the stock are interesting as 3 analysts out of 5 who provided ratings for TransMedics Group Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $19.20, which is -$19.49 below the current price. TMDX currently public float of 25.29M and currently shorts hold a 3.54% ratio of that float. Today, the average trading volume of TMDX was 361.20K shares.
TMDX’s Market Performance
TMDX stocks went up by 26.19% for the week, with a monthly jump of 61.21% and a quarterly performance of 172.66%, while its annual performance rate touched 109.02%. The volatility ratio for the week stands at 14.99% while the volatility levels for the past 30 days are set at 10.46% for TransMedics Group Inc.. The simple moving average for the period of the last 20 days is 46.51% for TMDX stocks with a simple moving average of 125.04% for the last 200 days.
Analysts’ Opinion of TMDX
Many brokerage firms have already submitted their reports for TMDX stocks, with JP Morgan repeating the rating for TMDX by listing it as a “Neutral.” The predicted price for TMDX in the upcoming period, according to JP Morgan is $15 based on the research report published on October 08th of the previous year 2020.
Oppenheimer, on the other hand, stated in their research note that they expect to see TMDX reach a price target of $25. The rating they have provided for TMDX stocks is “Outperform” according to the report published on April 07th, 2020.
TMDX Trading at 78.28% from the 50-Day Moving Average
After a stumble in the market that brought TMDX to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 6.09% of gains for the given period.
Volatility was left at 10.46%, however, over the last 30 days, the volatility rate increased by 14.99%, as shares surge +62.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +154.37% upper at present.
During the last 5 trading sessions, TMDX rose by +26.19%, which changed the moving average for the period of 200-days by +129.48% in comparison to the 20-day moving average, which settled at $27.15. In addition, TransMedics Group Inc. saw 94.42% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at TMDX starting from Gordon Stephen, who sale 10,000 shares at the price of $31.33 back on Feb 16. After this action, Gordon Stephen now owns 0 shares of TransMedics Group Inc., valued at $313,300 using the latest closing price.
TOBIN JAMES R, the Director of TransMedics Group Inc., sale 10,168 shares at $32.83 during a trade that took place back on Feb 09, which means that TOBIN JAMES R is holding 424,637 shares at $333,786 based on the most recent closing price.
Stock Fundamentals for TMDX
Current profitability levels for the company are sitting at:
- -125.42 for the present operating margin
- +57.79 for the gross margin
The net margin for TransMedics Group Inc. stands at -142.12. The total capital return value is set at -50.72, while invested capital returns managed to touch -57.47. Equity return is now at value -39.00, with -24.10 for asset returns.
Based on TransMedics Group Inc. (TMDX), the company’s capital structure generated 62.48 points at debt to equity in total, while total debt to capital is 38.45. Total debt to assets is 32.43, with long-term debt to equity ratio resting at 62.48. Finally, the long-term debt to capital ratio is 38.45.
When we switch over and look at the enterprise to sales, we see a ratio of 9.22, with the company’s debt to enterprise value settled at 0.16. The receivables turnover for the company is 4.72 and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.21.